Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Dr. Oz Weight-Loss Ingredient Endorsements On “Trial” In Senate Hearing

This article was originally published in The Tan Sheet

Executive Summary

Senator McCaskill quoted the daytime talk show host saying green coffee extract, raspberry ketone and garcinia cambogia are “miracles” for weight loss. Oz says he does not promote any brands as he tells his viewers about ingredients he expects will help in weight loss.

You may also be interested in...



Dr. Oz As Role Model? No Defense Against FTC Action On Weight Loss Claims

Weight loss supplement Pure Green Coffee marketer demonstrated “reckless indifference” in marketing the product, beginning after learning about the benefits of green coffee bean on The Dr. Oz Show, a federal judge says.

In Brief: Acetaminophen Warnings, OTC HSA Bill, Durbin’s Supplement Reg Bill

FDA adds acetaminophen warnings; CHPA suggests 4-aminophenol standard; OTC HSA bill in House; supplement registration bill reintroduced; FSMA user fees still on hold; more scrutiny of energy drinks; and Public Citizen pans OTC Oxytrol.

In Latest US OTC Switch, Ivermeticin 0.5% Lice Treatment Becomes Fully Nonprescription

FDA approved Arbor Pharmaceuticals' sNDA for an OTC switch of Sklice lice treatment. As it's been prescribed since its 2012 approval , Sklice will be available as a single-use lotion for topical treatment of head lice infestations in patients six months of age and older.

Topics

UsernamePublicRestriction

Register

LL1134409

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel